CARY, N.C.--(BUSINESS WIRE)--Cetero Research, an industry leader in clinical pharmacology, bioanalytical and specialty Phase II-IV services, announces strategic expansions in its San Antonio operations. The site has a new purpose-built, 100-bed facility designed to run clinical pharmacology studies in healthy, diabetic and obese participants. Well-known for conducting first-in-human, proof-of-concept studies and participating as a multicenter site in diabetes and obesity trials, the new facility consolidates its operations into one four-story building.
